Surgery Partners (NASDAQ:SGRY) Price Target Raised to $15.00

Surgery Partners (NASDAQ:SGRY) had its price objective hoisted by JPMorgan Chase & Co. from $14.00 to $15.00 in a research report report published on Monday morning,Benzinga reports. They currently have a neutral rating on the stock.

Several other research analysts have also recently weighed in on the stock. Benchmark reaffirmed a “buy” rating on shares of Surgery Partners in a report on Tuesday, August 11th. TD Cowen boosted their target price on Surgery Partners from $17.00 to $19.00 and gave the stock a “buy” rating in a research report on Tuesday, August 11th. Royal Bank Of Canada reduced their target price on Surgery Partners from $20.00 to $19.00 and set an “outperform” rating for the company in a research report on Tuesday, August 11th. Raymond James Financial set a $18.00 target price on Surgery Partners in a research note on Tuesday, August 11th. Finally, Zacks Research cut Surgery Partners from a “strong-buy” rating to a “hold” rating in a report on Monday, August 10th. Seven research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $19.00.

Surgery Partners Trading Up 2.1%

Shares of Surgery Partners stock opened at $13.93 on Monday. The company’s 50-day moving average price is $14.95 and its 200-day moving average price is $14.28. The company has a current ratio of 1.95, a quick ratio of 1.78 and a debt-to-equity ratio of 1.18. Surgery Partners has a 12-month low of $11.41 and a 12-month high of $23.44. The company has a market cap of $1.82 billion, a price-to-earnings ratio of -19.90, a PEG ratio of 3.75 and a beta of 1.92.

Surgery Partners (NASDAQ:SGRY) last posted its earnings results on Monday, August 10th. The company reported $0.10 earnings per share for the quarter, topping analysts’ consensus estimates of $0.06 by $0.04. Surgery Partners had a negative net margin of 2.63% and a positive return on equity of 0.88%. The business had revenue of $848.90 million for the quarter, compared to analyst estimates of $830.03 million. During the same quarter in the prior year, the firm posted $0.17 EPS. Surgery Partners’s revenue was up 2.7% on a year-over-year basis. On average, equities analysts expect that Surgery Partners will post 0.25 earnings per share for the current fiscal year.

Insider Buying and Selling at Surgery Partners

In other news, Director Teresa DeLuca bought 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 18th. The stock was bought at an average price of $14.35 per share, for a total transaction of $143,500.00. Following the transaction, the director directly owned 66,843 shares of the company’s stock, valued at $959,197.05. This represents a 17.59% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Squarepoint Ops LLC bought a new stake in shares of Surgery Partners in the 2nd quarter worth approximately $308,000. Varde Management L.P. grew its holdings in shares of Surgery Partners by 32.8% during the 2nd quarter. Varde Management L.P. now owns 1,003,447 shares of the company’s stock valued at $16,858,000 after purchasing an additional 248,009 shares during the last quarter. TD Waterhouse Canada Inc. grew its holdings in shares of Surgery Partners by 19.8% during the 2nd quarter. TD Waterhouse Canada Inc. now owns 166,411 shares of the company’s stock valued at $2,762,000 after purchasing an additional 27,559 shares during the last quarter. Penn Capital Management Company LLC purchased a new position in Surgery Partners in the 2nd quarter worth $2,941,000. Finally, Hsbc Holdings PLC raised its position in Surgery Partners by 54.5% in the 2nd quarter. Hsbc Holdings PLC now owns 2,958,912 shares of the company’s stock worth $48,912,000 after purchasing an additional 1,043,244 shares during the period.

About Surgery Partners

Surgery Partners, Inc (NASDAQ: SGRY) is a healthcare services company that owns and operates a network of ambulatory surgery centers and surgical hospitals in the United States. The company works with physicians and health systems to provide outpatient and same-day surgical care in settings outside traditional hospital facilities.

Its services cover a range of specialties, including orthopedics, pain management, gastroenterology, ophthalmology, gynecology, urology and other procedural areas.